Amy W. Schulman
Senior Vice President and General Counsel, Pfizer
Amy Schulman is Senior Vice President and General Counsel of Pfizer. She also is the company's Corporate Secretary and executive sponsor of its Global Women's Council, which aims to make Pfizer an employer of choice for women.
Amy joined Pfizer in June 2008 and saw the company through its $68 billion acquisition of Wyeth. She led a major reorganization of the Legal Division to align with Pfizer's new business-unit structure and broadened its scope to include lawyers in all markets. In early 2009, she spearheaded the Pfizer Legal Alliance, an innovative approach to engaging outside counsel. She is recognized as a leading voice for transforming the billable-hour model and for redefining the value of legal services.
Amy's commitment to clients, skill as a legal advocate and efforts to advance women have earned her accolades from many leading publications and organizations. In 2009, The National Law Journal named her to its inaugural list of the 20 Most Influential General Counsel, and Forbes magazine included her on its list of "The World's Most Powerful Women." In 2004, The American Lawyer recognized her as one of the 45 legal superstars under age 45.
Before coming to Pfizer, Amy was a partner at DLA Piper, where she was a member of the Board and Executive Policy Committees, and built and led the international law firm's mass tort and class-action practice. A Phi Beta Kappa graduate of Wesleyan University, Amy earned her J.D. from Yale Law School in 1989. She serves on the Board of Directors of Wesleyan and the Brooklyn Academy of Music.
